FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2894582328> ?p ?o ?g. }

• W2894582328 endingPage "e000406" @default.
• W2894582328 startingPage "e000406" @default.
• W2894582328 abstract "Programmed death ligand 1 (PD-L1) targeting immunotherapies, as pembrolizumab and nivolumab, have significantly improved outcome in patients with non-small cell lung cancer (NSCLC). Tobacco smoking is the number one risk factor for lung cancer and is linked to 80%-90% of these cancers. Smoking during cancer therapy may influence on radiotherapy and chemotherapy outcome. We aimed to review the knowledge in immunotherapy.A systematic review was done. We searched for documents and articles published in English language and registered in Cochrane Library, National Health Service (NHS) Centre for Reviews and Dissemination (CRD), Embase or Medline. The search terms were (A) (Lung cancer or NSCLC) with (pembrolizumab or nivolumab) with PD-L1 with (tobacco or smoking) and (B) Lung Neoplasms and Immunotherapy and (smoking cessation or patient compliance). 68 papers were detected and two more were added during review process (references) and six based on information from the manufacturers.Nine papers were selected. High PD-L1 expression (≥50%) was correlated with current/ever smoking history in three studies. Six studies revealed a higher overall response rate (ORR) among current/former smokers. The ORR was generally (six studies) better among the current/former smoker group. So also when tumours had a molecular 'smoking signature' (one study). This was probably due to a higher mutational burden. In two studies, minor or no difference was revealed.One study (KEYNOTE-024) compared former and current smokers, and documented pembrolizumab being more effective among former smokers than current smokers.Tobacco smoking patients with NSCLC generally have a higher PD-L1 tumour proportion score and experience a better ORR of immunotherapy than no smokers. There is little evidence on the effect of smoking during immunotherapy, but one study (KEYNOTE-024) may indicate survival gains of smoking cessation." @default.
• W2894582328 created "2018-10-12" @default.
• W2894582328 creator A5025585146 @default.
• W2894582328 creator A5044089012 @default.
• W2894582328 date "2018-01-01" @default.
• W2894582328 modified "2023-10-14" @default.
• W2894582328 title "Tobacco smoking and cessation and PD-L1 inhibitors in non-small cell lung cancer (NSCLC): a review of the literature" @default.
• W2894582328 cites W1971146628 @default.
• W2894582328 cites W1982488143 @default.
• W2894582328 cites W1987406532 @default.
• W2894582328 cites W2006575886 @default.
• W2894582328 cites W2042386784 @default.
• W2894582328 cites W2049553585 @default.
• W2894582328 cites W2052203615 @default.
• W2894582328 cites W2054609442 @default.
• W2894582328 cites W2060070314 @default.
• W2894582328 cites W2064056649 @default.
• W2894582328 cites W2071865120 @default.
• W2894582328 cites W2088877484 @default.
• W2894582328 cites W2098145437 @default.
• W2894582328 cites W2098414192 @default.
• W2894582328 cites W2104347254 @default.
• W2894582328 cites W2131876608 @default.
• W2894582328 cites W2152061559 @default.
• W2894582328 cites W2180481128 @default.
• W2894582328 cites W2198093519 @default.
• W2894582328 cites W2227435734 @default.
• W2894582328 cites W2310252196 @default.
• W2894582328 cites W2400514548 @default.
• W2894582328 cites W2508069933 @default.
• W2894582328 cites W2527905628 @default.
• W2894582328 cites W2560367415 @default.
• W2894582328 cites W2572174216 @default.
• W2894582328 cites W2574398598 @default.
• W2894582328 cites W2592465672 @default.
• W2894582328 cites W2605104598 @default.
• W2894582328 cites W2607087154 @default.
• W2894582328 cites W270104280 @default.
• W2894582328 cites W2740053090 @default.
• W2894582328 cites W2745601792 @default.
• W2894582328 cites W2745833545 @default.
• W2894582328 cites W2767796090 @default.
• W2894582328 cites W2783592711 @default.
• W2894582328 cites W2796582438 @default.
• W2894582328 cites W2910245285 @default.
• W2894582328 cites W4232599692 @default.
• W2894582328 doi "https://doi.org/10.1136/esmoopen-2018-000406" @default.
• W2894582328 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6173248" @default.
• W2894582328 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30305940" @default.
• W2894582328 hasPublicationYear "2018" @default.
• W2894582328 type Work @default.
• W2894582328 sameAs 2894582328 @default.
• W2894582328 citedByCount "73" @default.
• W2894582328 countsByYear W28945823282018 @default.
• W2894582328 countsByYear W28945823282019 @default.
• W2894582328 countsByYear W28945823282020 @default.
• W2894582328 countsByYear W28945823282021 @default.
• W2894582328 countsByYear W28945823282022 @default.
• W2894582328 countsByYear W28945823282023 @default.
• W2894582328 crossrefType "journal-article" @default.
• W2894582328 hasAuthorship W2894582328A5025585146 @default.
• W2894582328 hasAuthorship W2894582328A5044089012 @default.
• W2894582328 hasBestOaLocation W28945823281 @default.
• W2894582328 hasConcept C121608353 @default.
• W2894582328 hasConcept C126322002 @default.
• W2894582328 hasConcept C142724271 @default.
• W2894582328 hasConcept C143998085 @default.
• W2894582328 hasConcept C2776256026 @default.
• W2894582328 hasConcept C2776478404 @default.
• W2894582328 hasConcept C2777701055 @default.
• W2894582328 hasConcept C2777843972 @default.
• W2894582328 hasConcept C2780030458 @default.
• W2894582328 hasConcept C2780057760 @default.
• W2894582328 hasConcept C509974204 @default.
• W2894582328 hasConcept C71924100 @default.
• W2894582328 hasConcept C95190672 @default.
• W2894582328 hasConceptScore W2894582328C121608353 @default.
• W2894582328 hasConceptScore W2894582328C126322002 @default.
• W2894582328 hasConceptScore W2894582328C142724271 @default.
• W2894582328 hasConceptScore W2894582328C143998085 @default.
• W2894582328 hasConceptScore W2894582328C2776256026 @default.
• W2894582328 hasConceptScore W2894582328C2776478404 @default.
• W2894582328 hasConceptScore W2894582328C2777701055 @default.
• W2894582328 hasConceptScore W2894582328C2777843972 @default.
• W2894582328 hasConceptScore W2894582328C2780030458 @default.
• W2894582328 hasConceptScore W2894582328C2780057760 @default.
• W2894582328 hasConceptScore W2894582328C509974204 @default.
• W2894582328 hasConceptScore W2894582328C71924100 @default.
• W2894582328 hasConceptScore W2894582328C95190672 @default.
• W2894582328 hasIssue "6" @default.
• W2894582328 hasLocation W28945823281 @default.
• W2894582328 hasLocation W28945823282 @default.
• W2894582328 hasLocation W28945823283 @default.
• W2894582328 hasLocation W28945823284 @default.
• W2894582328 hasLocation W28945823285 @default.
• W2894582328 hasOpenAccess W2894582328 @default.
• W2894582328 hasPrimaryLocation W28945823281 @default.
• W2894582328 hasRelatedWork W2272044596 @default.

• next